|
| Andhra Pradesh ~ India ~ International ~ City ~ Entertainment ~ Business ~ Bullion ~ Forex ~ Sports ~ Technology ~ Health ~ Features |
| Lung Cancer ~ Lung Cancer ~ Breast Cancer ~ Heart attack ~ All Health Topics |
|
Home
/ Health News / 2008 / October 2008 / October 9, 2008 Scientists decode genome of parasite behind malaria relapse |
Love hormone helps us recognize familiar faces
Immune cells implicated in fatal seizures in viral meningitis
Sack lunches may not provide adequate nutrients to preschooler
Packing lunch for your child might not be a good idea, for a new study has found that sack lunches may not regularly provide adequate nutrients for the growth and development of young children. ANI
Health-monitoring system helps maintain older adults well-being
Many older adults want to remain active and independent for as long as possible. Now, researchers from University of Missouri suggest that installing health monitoring system can help keep check on the health of the elderly and ensure their privacy. ANI
New drug shows potential to treat angina, other cardiac problems
A compound, designed to prevent chest pains in heart patients, could act as a drug to treat angina and possibly other cardiac pathologies, according to a study on animals. ANI
Scientists at a New York University have decoded the complete genetic sequence of the parasite Plasmodium vivax - the leading cause of relapsing malaria - and compared it with the genomes of other species of malaria parasites.
London, Oct 9 : Scientists at a New York University have decoded the complete genetic sequence of the parasite Plasmodium vivax - the leading cause of relapsing malaria - and compared it with the genomes of other species of malaria parasites.
The discovery offers insight into distinctive genetic features of P. vivax, and may lead to new tools to prevent and treat P. vivax malaria.
Although the infection is rarely fatal, it causes severe clinical symptoms that include repeated episodes of high fever followed by headache, chills and profuse sweating, often accompanied by vomiting, diarrhea and enlargement of the spleen.
Patients treated for the primary blood stage infection but not specifically for dormant disease in the liver are at substantial risk of relapse.
Co-authors at the Institute for Genomic Research/J. Craig Venter Institute in Rockville, Md., and their colleagues, said that the P. vivax gene sequence will drive research in three key areas - study of the genetic diversity of P. vivax, the problem of drug resistance and the phenomenon of P. vivax relapse.
"Plasmodium vivax relapse presents serious challenges to scientists and doctors alike. Completion of the P. vivax genome promises to provide new insights into the biology of vivax malaria and new leads for therapies and vaccines," Nature quoted National Institute of Allergy and Infectious Diseases (NIAID) Director Anthony S. Fauci, M.D, as saying.
One limitation for researchers has been that P. vivax cannot be grown in the laboratory, making it a relatively neglected area of study.
"With the publication of the first genome sequence, we hope to reverse this trend and provide a resource for scientists to pursue studies on this important parasite," says lead author Jane M. Carlton, Ph.D., of the New York University Langone Medical Center.
Four species of Plasmodium parasite commonly cause malaria in humans: P. falciparum, P. malariae, P. ovale and P. vivax.
According to the researchers, although P. vivax resembles the other three species of human malaria parasites, it has novel gene families that encode for potential alternative pathways into red blood cells not recognized previously.
Importantly, Carlton's team identified some P. vivax genes with similarities to genes in other organisms, such as yeast, that are responsible for dormancy.
These genes may allow scientists to study the mechanisms of the dormant liver stage P. vivax and perhaps find ways to disrupt it.
The study appears in the Oct. 9 issue of Nature.
ANI
